A Quiz: Name That Health Care Model

Steven R. Peskin, MD, MBA, FACP

What do these characteristics bring to mind?

  • Flexible appointment scheduling
  • Advanced electronic communication
  • Care coordination
  • Counseling and education
  • Electronic prescribing
  • Electronic health record with patient portal

If you thought Level 3 Medical Home, you were correct. If you thought retainer (concierge) practice, you would also be correct. To me, it seems eminently rational for people who have sufficient discretionary income to choose to use it to obtain more rapid access to a personal physician of her/ his choosing through a retainer (concierge) practice. The advantages might be more time spent in conversation (in the office, over the phone, via e-mail or text messaging, in video conferences), more in-depth condition or prevention education, coaching, counseling, and/or less waiting time. Some in the medical profession have raised the question of the ethics of retainer practices. An excerpt from an Annals of Internal Medicine editorial: "I am less charitable, however, toward concierge physicians and am surprised by the neutrality with which the medical community has addressed their work. First, each of us has vowed to treat without exception all who seek [our] ministrations,and limiting one's practice to several hundred wealthy patients undermines this tenet of our profession. Even though economic realities and schedule limitations dictate that some physicians maintain a certain payer mix or eventually close their panels to new patients, I am certain that the legendary physicians of our profession would be embarrassed by the criteria some of our colleagues have used in selecting which patients they will and will not see." Ann Intern Med. 2010;152:391­392. http://www.annals.org/content/152/6/391.abstract "Treat without exception all who seek [our] ministrations" is from the Hippocratic Oath, a poignant ethical pledge believed to have been written in the late 5th century BCE. Our modern reality is that there are many constraints on how clinicians practice, the scope of that practice, where they practice, the patients that they treat, and the machinations of how that care is reimbursed. As a volunteer faculty physician in a Federally Qualified Health Center, I find this challenge of ensuring adequate access to care to be abundantly evident. My own view: Health care practitioners should dedicate some time to service in situations with wider access, often pro bono, whether the field be medicine, nursing, pharmacy, or allied health professions. This may be difficult or impossible in a retainer medical practice, but that does not preclude service elsewhere. Retainer practices have their place, but they will only be viable if the clinicians engaged in that model meet or exceed the expectations of their patients by providing a comfortable medical home for them. It's that rational.

Steven R. Peskin, MD, MBA, FACP is executive vice president and chief medical officer of MediMedia USA, which publishes Managed Care. He is Associate Clinical Professor of Medicine at the University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School

Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.